Citigroup Cuts Xylem (XYL) Price Target to $148

Citigroup has reaffirmed its Buy rating on Xylem, adjusting its price target to $148.0, a 42.75% upside from the current price.

By EarningsIQ Research Desk · Published Oct 16, 2026, 2:18 PM EDT

Reviewed by automated data checks against the source data. How we make and check alerts

Citigroup cut its price target on Xylem Inc. ($XYL) to $148 from $172 on October 12, 2026, and rates the stock "Buy".

Since the rating, $XYL is up 1.4% to date (from the $102.59 close on Oct 12, 2026).

XYL Xylem Inc.

$104.05 -23.27% year to date

Daily close · Oct 16, 2026

Key Points

On October 12, 2026, Citigroup reiterated its Buy rating on Xylem Inc. (NYSE: XYL) and set a new price target of $148.0, down from $172.0.
Citigroup's $148 price target implies 42.75% upside from Xylem Inc.'s ($XYL) current $103.68 share price.
The stock recently traded at $103.68, which is about 29.9% below the new target price.
Xylem has a dividend rate of $1.72 and will report its next earnings on November 3, 2026.

Get $XYL trade alerts by text

We text you when insiders, Congress or big funds trade $XYL. Free.

Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Xylem Inc. alert may contain errors. Disclosures

Citigroup has reaffirmed its Buy rating on Xylem Inc. (NYSE: XYL) on October 12, 2026, while lowering its price target from $172.0 to $148.0. This adjustment reflects the firm's ongoing confidence in the company despite the reduced target.

Citigroup's Call on Xylem

Citigroup maintained its Buy rating on Xylem and set a new price target of $148.0, down from the previous target of $172.0. This indicates a strategic shift in expectations, but the firm remains optimistic about the company's prospects.

Other Institutional Activity in Xylem

Several other major funds have adjusted their positions in Xylem recently. Blackrock Inc. reduced its holdings by 615,686 shares, ending with 25,037,896 shares valued at approximately $2.6 billion. Vanguard Capital Management LLC also trimmed its position by 283,116 shares, now holding 15,533,420 shares worth about $1.6 billion. Meanwhile, State Street Corporation grew its stake by 271,508 shares, bringing its total to 11,444,669 shares valued at around $1.2 billion.

Xylem Inc. Stock Down 3.6%

Xylem shares recently traded at $103.68 as of October 16, 2026. This price is significantly below Citigroup's new target of $148.0, suggesting potential upside if the company meets its growth expectations. The stock has been volatile, reflecting broader market trends in the industrial sector.

12-month forecast

$XYL price target

Xylem Inc. daily closes and this analyst's $148 target. Not advice.

Recent Earnings

For the trailing twelve months, Xylem reported revenue of approximately $9.13 billion and earnings per share (EPS) of $4.19. The company's net margin is 11.2%, and its return on equity (ROE) stands at 9.2%. Xylem is scheduled to release its next earnings report on November 3, 2026, which could provide further insights into its financial performance.

Insider Buying and Selling at Xylem Inc.

Insider transactions at Xylem include selling activity by Director Victoria D. Harker, who sold 1,700 shares at an average price of $148.14 on November 4, 2025. Director Jerome A. Peribere purchased 1,210 shares at $116.61 on May 4, 2026, totaling about $141,098. Additionally, Officer Geri-Michelle McShane sold 4,269 shares at $117.46 on May 7, 2026, valued at approximately $501,437.

Analysts Set New Price Targets

On October 12, 2026, Citigroup maintained its Buy rating on Xylem with a new target of $148.0, down from $172.0. Other analysts also provided updates, with Jefferies maintaining a Buy rating and adjusting its target from $145.0 to $150.0 on August 24, 2026. Barclays later set a target of $139.0 on October 13, 2026, maintaining an Overweight rating.

About Xylem

Xylem Inc. designs and manufactures products and solutions for water and wastewater applications. The company operates in various sectors, including utilities and industrial markets. Its recent adjustments in analyst ratings highlight ongoing interest in its potential for growth despite market challenges.

Bottom Line

Investors should keep an eye on Xylem's upcoming earnings report on November 3, 2026, which could provide further insights into its financial health. Citigroup's adjustment in the target price reflects a cautious but still optimistic outlook for the company's future performance.